Adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: analysis of a national specialty pharmacy database-Reference-Cited by-同舟云学术

Adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: analysis of a national specialty pharmacy database

Published:2021-04-23 Issue:1 Volume:10 Page:62-67
ISSN:2155-6660
Container-title:Journal of Drug Assessment
language:en
Short-container-title:Journal of Drug Assessment

Author:

Mehta Zumi¹^ORCID,Kamal Khalid M.²^ORCID,Miller Richard³,Covvey Jordan R.¹^ORCID,Giannetti Vincent¹

Affiliation:

1. Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, USA

2. Department of Pharmaceutical Systems and Policy, Health Sciences Center, West Virginia University School of Pharmacy, Morgantown, WV, USA

3. AllianceRx Walgreens Prime, Pittsburgh, PA, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/21556660.2021.1912352

Reference29 articles.

1. Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders

2. Cystic fibrosis

3. Cystic Fibrosis | National Heart, Lung, and Blood Institute (NHLBI) [Internet]. [cited 2019 Oct 5]. Available from: https://www.nhlbi.nih.gov/health-topics/cystic-fibrosis.

4. Cystic fibrosis: Insight into CFTR pathophysiology and pharmacotherapy

5. Cystic Fibrosis Mutation Database: Statistics [Internet]. [cited 2020 Apr 19]. Available from: http://genet.sickkids.on.ca/StatisticsPage.html.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic fibrosis;Nature Reviews Disease Primers;2024-08-08

2. Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review;European Respiratory Review;2024-07

3. Cystic fibrosis;The Transition of Respiratory Care: from Child to Adult;2024-06-01

4. Real-world impact of Elexacaftor-Tezacaftor-Ivacaftor treatment in young people with Cystic Fibrosis: A longitudinal study;2024-03-16

5. Mukoviszidose: Management im Zeitalter der CFTR-Modulator-Therapie;Pädiatrie up2date;2024-03